Gerhardinger C, Taneda S, Marion M S, Monnier V M
Institute of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106.
J Biol Chem. 1994 Nov 4;269(44):27297-302.
Sugars react nonenzymatically with protein amino groups to form a ketoamine adduct (Amadori product), which leads to the formation of advanced glycation end-products. These compounds are involved in the development of tissue modifications such as cross-linking and fluorescence in diabetes and aging. Searching for an enzyme to reverse protein glycation, we isolated a Pseudomonas sp. soil strain growing selectively on the Amadori product epsilon-fructosyl-aminocaproate. An Amadori product binding protein (ABP) was purified from the bacterial extract by single-step affinity chromatography on glycated lysine-Sepharose. The protein, a monomer of 45 kDa, did not bind to unglycated or NaBH4-reduced glycated lysine-Sepharose suggesting specificity for the Amadori compound. The concentration-dependent binding of glycated aminocaproate showed saturation with Kd = 1.49 microM and Bmax = 17.63 nmol/mg of protein corresponding to 0.8 mol/mol of protein. The binding of epsilon-1-[14C]fructosyl-aminocaproate to the protein was inhibited by other glucose-derived Amadori products, but not by free sugars, unglycated amines, or ribated lysine. The sequence of the first 16 NH2-terminal amino acids and a GenBank search revealed that ABP is a novel protein. Its synthesis was inducible by growth of the organism in Amadori product. Immunoblotting studies showed that ABP is not found in cell extracts from other prokaryotes, yeast, or liver homogenate and does not bind Amadori products in glycated proteins. ABP has no enzymatic activity toward glycated substrates and may thus have transport or permease function for glycated amino acids.
糖类与蛋白质氨基发生非酶促反应,形成酮胺加合物(阿马多里产物),进而导致晚期糖基化终产物的形成。这些化合物参与了糖尿病和衰老过程中诸如交联和荧光等组织变化的发展。为了寻找一种能逆转蛋白质糖基化的酶,我们分离出了一株假单胞菌属土壤菌株,该菌株能在阿马多里产物ε-果糖基-氨基己酸上选择性生长。通过在糖化赖氨酸-琼脂糖上进行单步亲和层析,从细菌提取物中纯化出一种阿马多里产物结合蛋白(ABP)。该蛋白为45 kDa的单体,不与未糖化或经硼氢化钠还原的糖化赖氨酸-琼脂糖结合,表明其对阿马多里化合物具有特异性。糖化氨基己酸的浓度依赖性结合显示出饱和状态,Kd = 1.49 μM,Bmax = 17.63 nmol/mg蛋白,相当于0.8 mol/mol蛋白。ε-1-[14C]果糖基-氨基己酸与该蛋白的结合受到其他葡萄糖衍生的阿马多里产物的抑制,但不受游离糖、未糖化胺或核糖化赖氨酸的抑制。前16个NH2末端氨基酸的序列以及GenBank搜索表明ABP是一种新型蛋白。其合成可由该生物体在阿马多里产物中的生长诱导。免疫印迹研究表明,在其他原核生物、酵母或肝脏匀浆的细胞提取物中未发现ABP,且其不与糖化蛋白中的阿马多里产物结合。ABP对糖化底物没有酶活性,因此可能对糖化氨基酸具有转运或通透酶功能。